Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Step by step instructions to Protect Your Retirement with Senior Protection. - 2Change Your Physical make-up: Compelling Activities for Muscle Building
- 3Former hostage Eitan Mor on Hamas: ‘They will not give up until the last Israeli is gone'
- 4Do-It-Yourself Home Style on a Careful spending plan: Imaginative Thoughts and Tasks
- 5Mom finds out she has cancer after noticing something was off while breastfeeding
- Step by step instructions to Pick A Keep money with High Fixed Store Loan costs
- Research highlights potential dangers of ultra-processed foods for women under 50 regarding precancerous polyps
- NASA's Voyager 1 set to achieve historic distance from Earth
- 5 Movies That Leaving an Imprint with Inventive Innovation
- Instructions to Boost Your True capacity with a Brain research Degree
- Instructions to Pick the Best Album Rates for Your Investment funds
- Holiday weather forecast: Where travelers can expect a wintry mix, flooding and record warmth across the U.S.
- Lilly, Novo lock horns in India's obesity drug race
- See the metal guts of a satellite in this wild X-ray view | Space photo of the day for Dec. 4, 2025
